Carson Wealth (CWM LLC)
MBRX icon

Carson Wealth (CWM LLC)’s Moleculin Biotech MBRX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio MBRX Stock Details MBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Hold
0
– – – 2820
2021
Q1 		– Hold
0
– – – 2820
2020
Q4 		– Hold
0
– – – 2819
2020
Q3 		– Hold
0
– – – 2819
2020
Q2 		– Hold
0
– – – 2818
2020
Q1 		– Hold
0
– – – 2817
2019
Q4 		– Hold
0
– – – 2810
2019
Q3 		– Hold
0
– – – 2811
2019
Q2 		– Hold
0
– – – 2813
2019
Q1 		– Hold
0
– – – 2812

Other funds holding MBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sio Capital Management
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Susquehanna Fundamental Investments
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $5.32B AUM 30.24% 1-Year Est. Return
GSA Capital Partners
GSA Capital Partners London, United Kingdom $1.59B AUM 39.8% 1-Year Est. Return